Monitoring proteasome activity in cellulo and in living animals by bioluminescent imaging: Technical considerations for design and use of genetically encoded reporters

Methods in Enzymology

Volumn 399, Issue , 2005, Pages 512-530

  Gross, Shimon ^a   Piwnica Worms, David ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; LUCIFERASE; PROTEASOME; UBIQUITIN;

BIOLUMINESCENCE; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; IMAGING SYSTEM; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; REVIEW;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; GENES, REPORTER; I-KAPPA B PROTEINS; LUCIFERASES; LUMINESCENCE; MICE; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

ANIMALIA;

EID: 12344266790     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)99035-6     Document Type: Review

References (49)

1. Aberle H., Bauer A., Stappert J., Kispert A., and Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway EMBO J. 16 1997 3797 3804
2. Barroga C.F., Stevenson J.K., Schwarz E.M., and Verma I.M. Constitutive phosphorylation of I kappa B alpha by casein kinase II Proc. Natl. Acad. Sci. USA 92 1995 7637 7641
3. Bhaumik S., and Gambhir S. Optical imaging of Renilla luciferase reporter gene expression in living mice Proc. Natl. Acad. Sci. USA 99 2001 377 382
4. Blagosklonny M.V., Wu G.S., Omura S., and el-Deiry W.S. Proteasome-dependent regulation of p21WAF1/CIP1 expression Biochem. Biophys. Res. Commun. 227 1996 564 569
5. Bloom J., and Pagano M. To be or not to be ubiquitinated? Cell Cycle 3 2004 138 140
6. Bross P.F., Kane R., Farrell A.T., Abraham S., Benson K., Brower M.E., Bradley S., Gobburu J.V., Goheer A., Lee S.L., Leighton J., Liang C.Y., Lostritto R.T., McGuinn W.D., Morse D.E., Rahman A., Rosario L.A., Verbois S.L., Williams G., Wang Y.C., and Pazdur R. Approval summary for bortezomib for injection in the treatment of multiple myeloma Clin. Cancer Res. 10 2004 3954 3964
7. Carlsen H., Moskaug J., Fromm S., and Blomhoff R. In vivo imaging of NF-κB activity J. Immunol. 168 2002 1441 1446
8. Chaudhuri T., Rogers B., Buchsbaum D., Mountz J., and Zinn K. A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts Gynecol. Oncol. 83 2001 432 438
9. Contag C., Spilman S., Contag P., Oshiro M., Eames B., Dennery P., Stevenson D., and Benaron D. Visualizing gene expression in living mammals using a bioluminescent reporter Photochem. Photobiol. 66 1997 523 531
10. Dantuma N.P., Lindsten K., Glas R., Jellne M., and Masucci M.G. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome- dependent proteolysis in living cells Nat. Biotechnol. 18 2000 538 543
11. Elliott P.J., Zollner T.M., and Boehncke W.H. Proteasome inhibition: A new anti-inflammatory strategy J. Mol. Med. 81 2003 235 245
12. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle Cell 109 Suppl. 2002 S81 S96
13. Hospers G., Calogero A., van Waarde A., Doze P., Vaalburg W., Mulder N., and de Vries E. Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography Cancer Res. 60 2000 1488 1491
14. Jacobs M.D., and Harrison S.C. Structure of an IkappaBalpha/NF-kappaB complex Cell 95 1998 749 758
15. Johnson E., Bartel B., Seufert W., and Varshavsky A. Ubiquitin as a degradation signal EMBO J. 11 1992 497 505
16. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity Annu. Rev. Immunol. 18 2000 621 663
17. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-kappaB in cancer: From innocent bystander to major culprit Nat. Rev. Cancer 2 2002 301 310
18. Kisselev A., and Goldberg A. Proteasome inhibitors: From research tools to drug candidates Chem. Biol. 8 2001 739 758
19. Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W.Y., Beguinot L., Geiger B., and Yarden Y. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor Genes Dev. 12 1998 3663 3674
20. Li B., and Dou Q.P. Bax degradation by the ubiquitin/proteasome-dependent pathway: Involvement in tumor survival and progression Proc. Natl. Acad. Sci. USA 97 2000 3850 3855
21. Li Q., and Verma I.M. NF-kappaB regulation in the immune system Nat. Rev. Immunol. 2 2002 725 734
22. Liu F., Song Y., and Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA Gene Ther. 6 1999 1258 1266
23. Luker G., Pica C., Song J., Luker K., and Piwnica-Worms D. Imaging 26S proteasome activity and inhibition in living mice Nat. Med. 9 2003 969 973
24. Luker G., Sharma V., Pica C., Dahlheimer J., Li W., Ochesky J., Ryan C., Piwnica-Worms H., and Piwnica-Worms D. Noninvasive imaging of protein-protein interactions in living animals Proc. Natl. Acad. Sci. USA 99 2002 6961 6966
25. Luker G., Sharma V., Pica C., Prior J., Li W., and Piwnica-Worms D. Molecular imaging of protein-protein interactions: Controlled expression of p53 and large T antigen fusion proteins in vivo Cancer Res. 63 2003 1780 1788
26. Luker K., and Piwnica-Worms D. Optimizing luciferase protein fragment complementation for bioluminescent imaging of protein-protein interactions in live cells and animals Methods Enzymol. 385 2004 349 360
27. Luker K.E., Smith M.C., Luker G.D., Gammon S.T., Piwnica-Worms H., and Piwnica-Worms D. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals Proc. Natl. Acad. Sci. USA 101 2004 12288 12293
28. Maclaren D., Gambhir S., Satyamurthy N., Barrio J., Sharfstein S., Totykuni T., Wu L., Berk A., Cherry S., Phelps M., and Herschman H. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals Gene Ther. 6 1999 785 791
29. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., and Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275
30. Moll U.M., and Petrenko O. The MDM2-p53 interaction Mol. Cancer Res. 1 2003 1001 1008
31. Ozawa T., Kaihara A., Sato M., Tachihara K., and Umezawa Split luciferase as an optical probe for detecting protein-protein interactions in mammalian cells based on protein splicing Anal. Chem. 73 2001 2516 2521
32. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., and Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science 269 1995 682 685
33. Paulmurugan R., Massoud T., Huang J., and Gambhir S. Molecular imaging of drug-modulated protein-protein interactions in living subjects Cancer Res. 64 2004 2113 2119
34. Paulmurugan R., Umezawa Y., and Gambhir S.S. Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies Proc. Natl. Acad. Sci. USA 99 2002 15608 15613
35. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., and Gerritsen M.E. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo J. Biol. Chem. 272 1997 21096 21103
36. Place R.F., Haspeslagh D., Hubbard A.K., and Giardina C. Cytokine-induced stabilization of newly synthesized I(kappa)B-alpha Biochem. Biophys. Res. Commun. 283 2001 813 820
37. Reinheckel T., Sitte N., Ullrich O., Kuckelkorn U., Davies K.J., and Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress Biochem. J. 335 Pt 3 1998 637 642
38. Rettig M.P., Ritchey J.K., Prior J.L., Haug J.S., Piwnica-Worms D., and DiPersio J.F. Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation J. Immunol. 173 2004 3620 3630
39. Robinson C.R., and Sauer R.T. Optimizing the stability of single-chain proteins by linker length and composition mutagenesis Proc. Natl. Acad. Sci. USA 95 1998 5929 5934
40. Sharma V., Luker G., and Piwnica-Worms D. Molecular imaging of gene expression and protein function in vivo with PET and SPECT J. Magn. Reson. Imaging 16 2002 336 351
41. Stack J., Whitney M., Rodems S., and Pollok B. A ubiquitin-based tagging system for controlled modulation of protein stability Nat. Biotechnol. 18 2000 1298 1302
42. Streetz K.L., Wustefeld T., Klein C., Kallen K.J., Tronche F., Betz U.A., Schutz G., Manns M.P., Muller W., and Trautwein C. Lack of gp130 expression in hepatocytes promotes liver injury Gastroenterology 125 2003 532 543
43. Tjuvajev J.G., Stockhammer G., Desai R., Uehara H., Watanabe K., Gansbacher B., and Blasberg R.G. Imaging the expression of transfected genes in vivo Cancer Res. 55 1995 6126 6132
44. Voorhees P.M., Dees E.C., O'Neil B., and Orlowski R.Z. The proteasome as a target for cancer therapy Clin. Cancer Res. 9 2003 6316 6325
45. Wang X., Rosol M., Ge S., Peterson D., McNamara G., Pollack H., Kohn D.B., Nelson M.D., and Crooks G.M. Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging Blood 102 2003 3478 3482
46. Weissleder R., Moore A., Mahmood U., Bhorade R., Benveniste H., Chicocca E., and Basilion J. In vivo magnetic resonance imaging of transgene expression Nat. Med. 6 2000 351 355
47. Wojcik C., and Di Napoli M. Ubiquitin-proteasome system and proteasome inhibition: New strategies in stroke therapy Stroke 35 2004 1506 1518
48. Yang M., Baranov E., Jiang P., Sun F.-X., Li X.-M., Li L., Hasegawa S., Bouvet M., Al-Tuwaijri M., Chishima T., Shimada H., Moossa A., Penman S., and Hoffman R. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases Proc. Natl. Acad. Sci. USA 97 2000 1206 1211
49. Zhang G.J., Safran M., Wei W., Sorensen E., Lassota P., Zhelev N., Neuberg D.S., Shapiro G., and Kaelin W.G. Jr. Bioluminescent imaging of Cdk2 inhibition in vivo Nat. Med. 10 2004 643 648